Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death

Nuclear Medicine and Biology
J ToretskyR C Mease

Abstract

The clinical response to antitumor therapy is measured using imaging, such as CT or MRI, 6-12 weeks following chemotherapy treatment. The images at that time reflect both tumor cell death and new growth. Therefore, the amount of tumor cell death caused by chemotherapy cannot be efficiently quantified with current imaging modalities. A quantitative measurement of tumor cell death immediately following chemotherapy is needed to help validate both new agents and to optimize administration of existing therapies. Annexin V is a 36kD protein that binds to exposed phosphatidylserine (PS) on dying cells. In order to synthesize a probe that can detect cell death in vivo, the positron emitter F-18 was conjugated to annexin V via the compound N- succinimidyl-4-[18F]fluorobenzoate, [18F]SFB. The decay corrected radiochemical yield of F-18 labeled annexin V from 18F fluoride was 17.6 +/- 5.6% (n = 4) in three hours. The stepwise radiochemical yield of the conjugation step with annexin V was as high as 70% when a protein concentration of 5 mg/ml was used. Cancer cells treated with the chemotherapeutic agent, etoposide, showed an 88% increase in the binding of F-18 labeled annexin V compared to untreated cells. We conclude that [18F] labeled ...Continue Reading

References

Apr 1, 1986·Cancer Genetics and Cytogenetics·J Whang-PengM A Israel
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·F G BlankenbergH W Strauss
Aug 5, 1999·Journal of the National Cancer Institute·K A GelmonP Workman
Dec 14, 1999·European Journal of Nuclear Medicine·K OhtsukiH W Strauss
Dec 28, 1999·Trends in Cell Biology·Z Song, H Steller
Mar 23, 2000·Cardiovascular Research·W L van HeerdeC P Reutelingsperger
Mar 23, 2000·Cancer Metastasis Reviews·P A Edwards
Sep 15, 2000·Journal of Immunological Methods·I VermesC Reutelingsperger
Nov 4, 2000·Stroke; a Journal of Cerebral Circulation·H D'ArceuilF G Blankenberg
Mar 31, 2001·Cancer Biotherapy & Radiopharmaceuticals·D J YangD A Podoloff
Sep 19, 2002·Bioconjugate Chemistry·Jonathan F TaitDonald F Gibson
Feb 8, 2003·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·S ZijlstraW Burchert

❮ Previous
Next ❯

Citations

Oct 22, 2010·Journal of Neural Transmission·X ZhangCheng Wang
Sep 6, 2005·Amino Acids·R Bergmann, J Pietzsch
Dec 15, 2012·Apoptosis : an International Journal on Programmed Cell Death·Ming-Wei WangShu-Han Sun
Jan 27, 2011·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·David ThononAndré Luxen
May 26, 2005·Bioorganic & Medicinal Chemistry·Roger G Hanshaw, Bradley D Smith
May 10, 2005·Nuclear Medicine and Biology·Bronwen DekkerJamal Zweit
Sep 20, 2012·Bioconjugate Chemistry·Bryan A Smith, Bradley D Smith
Jul 30, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Xuan ZhangCheng Wang
May 25, 2006·Current Opinion in Oncology·Scott M Schuetze
May 9, 2013·Nuclear Medicine Communications·Haifei WuYifan Zhang
Jul 7, 2011·Journal of Visualized Experiments : JoVE·Shuang HouClifton Kwang-Fu Shen
Oct 9, 2014·BioMed Research International·Md Ashrafuzzaman
Nov 11, 2014·TheScientificWorldJournal·Kazuma Ogawa, Miho Aoki
Oct 16, 2012·Nuclear Medicine and Biology·Annie OgasawaraJan Marik
Jan 10, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Quang-Dé NguyenEric O Aboagye
Jul 1, 2011·Drug Discovery Today. Technologies·Jan MarikNicholas van Bruggen
Jun 28, 2011·Chinese Medical Sciences Journal = Chung-kuo I Hsüeh K'o Hsüeh Tsa Chih·Ting-Ting He, Jia-He Tian
Sep 22, 2010·Advanced Drug Delivery Reviews·Zibo Li, Peter S Conti
Aug 15, 2009·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Tiantian MouYunchuan Ma
Jul 18, 2006·Nuclear Medicine and Biology·Archana MukherjeeMeera Venkatesh
Dec 7, 2006·Neuroimaging Clinics of North America·Dawid Schellingerhout, Juri Gelovani
Feb 13, 2013·Journal of Applied Toxicology : JAT·Xuan ZhangWilliam Slikker
Aug 29, 2006·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Jan Marik, Julie L Sutcliffe
Apr 18, 2006·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·S ZijlstraW Burchert
Apr 12, 2005·Nuclear Medicine and Biology·Bronwen DekkerJamal Zweit
Apr 25, 2006·Journal of the American College of Cardiology·John R DaviesJagat Narula
Oct 28, 2016·Neurotoxicology and Teratology·X ZhangM G Paule
Mar 13, 2018·Medicinal Research Reviews·Anna A RybczynskaAren van Waarde
Sep 11, 2018·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Xuan ZhangChe Wang
Apr 28, 2011·Molecular Imaging·Christel VangestelChristophe Van de Wiele
Jan 27, 2019·Apoptosis : an International Journal on Programmed Cell Death·Melinda WuestFrank Wuest
Apr 4, 2021·International Journal of Molecular Sciences·Christophe Van de WieleMaes Alex
Jul 17, 2008·Bioconjugate Chemistry·Xuehe LiJonathan F Tait
Oct 19, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mohan DossJian Q Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis